Lipocine (LPCN) vs Radiopharm Theranostics (RADX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Lipocine (LPCN) has outperformed Radiopharm Theranostics (RADX) over the past year, losing 31.7% versus a loss of 83.7%. Radiopharm Theranostics is the larger company by market cap ($16.8 million vs $16.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | LPCN | RADX |
|---|---|---|
| Share price | $1.99 | $1.15 |
| Market cap | $16.41M | $16.78M |
| 1-day change | -9.52% | 0.00% |
| YTD return | -72.60% | -77.97% |
| 1-year return | -31.68% | -83.66% |
| 5-year return | -88.55% | — |
| EPS (TTM) | $-1.85 | $-3.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $12.37 | $16.25 |
| 52-week low | $1.81 | $1.00 |
| Distance from 52-week high | -83.91% | -92.92% |
| Average volume | 1.68M | 84.62K |
| Shares outstanding | 8.24M | 14.59M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LPCN has outperformed RADX by 52.0 percentage points over the past year.
LPCN vs RADX FAQ
Which is bigger, Lipocine or Radiopharm Theranostics?
Radiopharm Theranostics (RADX) is larger, with a market capitalization of $16.78M compared with $16.41M for Lipocine (LPCN).
Which stock has performed better over the past year, LPCN or RADX?
LPCN returned -31.68% over the past 12 months, compared with -83.66% for RADX (price return, excluding dividends). Past performance does not predict future results.
Are Lipocine and Radiopharm Theranostics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.